Fidelity Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.41B | Sell |
64,961,641
-2,700,005
| -4% | -$143M | 0.15% | 111 |
|
|
2026
Q1 | $3.73B | Buy |
67,661,646
+192,237
| +0.3% | +$10.4M | 0.2% | 74 |
|
|
2025
Q4 | $3.31B | Buy |
67,469,409
+1,325,909
| +2% | +$61.8M | 0.17% | 94 |
|
|
2025
Q3 | $2.85B | Buy |
66,143,500
+5,139,956
| +8% | +$201M | 0.15% | 107 |
|
|
2025
Q2 | $2.34B | Buy |
61,003,544
+883,027
| +1% | +$33.7M | 0.13% | 119 |
|
|
2025
Q1 | $2.33B | Buy |
60,120,517
+7,297,485
| +14% | +$267M | 0.15% | 110 |
|
|
2024
Q4 | $1.79B | Buy |
52,823,032
+23,814,104
| +82% | +$857M | 0.11% | 145 |
|
|
2024
Q3 | $1.19B | Buy |
29,008,928
+2,224,345
| +8% | +$91M | 0.07% | 232 |
|
|
2024
Q2 | $1.03B | Buy |
26,784,583
+2,203,361
| +9% | +$92.7M | 0.07% | 246 |
|
|
2024
Q1 | $1.05B | Buy |
24,581,222
+5,215,091
| +27% | +$215M | 0.07% | 247 |
|
|
2023
Q4 | $718M | Buy |
19,366,131
+1,266,618
| +7% | +$45.5M | 0.06% | 312 |
|
|
2023
Q3 | $656M | Buy |
18,099,513
+1,291,161
| +8% | +$45.8M | 0.06% | 302 |
|
|
2023
Q2 | $599M | Buy |
16,808,352
+1,331,920
| +9% | +$47.8M | 0.05% | 365 |
|
|
2023
Q1 | $551M | Buy |
15,476,432
+515,951
| +3% | +$18.1M | 0.05% | 376 |
|
|
2022
Q4 | $526M | Buy |
14,960,481
+892,886
| +6% | +$29.7M | 0.05% | 368 |
|
|
2022
Q3 | $414M | Sell |
14,067,595
-13,763
| -0.1% | -$522K | 0.04% | 417 |
|
|
2022
Q2 | $766M | Buy |
14,081,358
+549,008
| +4% | +$30.3M | 0.08% | 248 |
|
|
2022
Q1 | $737M | Sell |
13,532,350
-665,755
| -5% | -$36.2M | 0.06% | 313 |
|
|
2021
Q4 | $783M | Buy |
14,198,105
+382,175
| +3% | +$19.9M | 0.06% | 308 |
|
|
2021
Q3 | $660M | Buy |
13,815,930
+234,147
| +2% | +$11.8M | 0.05% | 338 |
|
|
2021
Q2 | $676M | Sell |
13,581,783
-137,387
| -1% | -$6.6M | 0.05% | 347 |
|
|
2021
Q1 | $612M | Sell |
13,719,170
-1,769,636
| -11% | -$80.3M | 0.05% | 363 |
|
|
2020
Q4 | $712M | Sell |
15,488,806
-321,753
| -2% | -$14.8M | 0.06% | 300 |
|
|
2020
Q3 | $744M | Sell |
15,810,559
-161,132
| -1% | -$8.07M | 0.08% | 230 |
|
|
2020
Q2 | $814M | Buy |
15,971,691
+405,977
| +3% | +$20.8M | 0.09% | 198 |
|
|
2020
Q1 | $737M | Buy |
15,565,714
+165,654
| +1% | +$8.84M | 0.1% | 183 |
|
|
2019
Q4 | $905M | Sell |
15,400,060
-125,195
| -0.8% | -$6.96M | 0.1% | 191 |
|
|
2019
Q3 | $828M | Buy |
15,525,255
+909,354
| +6% | +$46.8M | 0.1% | 200 |
|
|
2019
Q2 | $731M | Buy |
14,615,901
+657,511
| +5% | +$33M | 0.09% | 225 |
|
|
2019
Q1 | $729M | Sell |
13,958,390
-123,170
| -0.9% | -$6.15M | 0.09% | 226 |
|
|
2018
Q4 | $673M | Sell |
14,081,560
-1,183,459
| -8% | -$58.3M | 0.09% | 204 |
|
|
2018
Q3 | $766M | Buy |
15,265,019
+262,177
| +2% | +$13.3M | 0.09% | 212 |
|
|
2018
Q2 | $756M | Sell |
15,002,842
-173,918
| -1% | -$8.76M | 0.09% | 217 |
|
|
2018
Q1 | $741M | Sell |
15,176,760
-567,809
| -4% | -$26.4M | 0.09% | 242 |
|
|
2017
Q4 | $698M | Sell |
15,744,569
-174,337
| -1% | -$8.05M | 0.08% | 260 |
|
|
2017
Q3 | $808M | Sell |
15,918,906
-4,100,515
| -20% | -$208M | 0.1% | 214 |
|
|
2017
Q2 | $1.08B | Buy |
20,019,421
+1,111,391
| +6% | +$59.2M | 0.13% | 161 |
|
|
2017
Q1 | $996M | Buy |
18,908,030
+1,985,607
| +12% | +$101M | 0.13% | 167 |
|
|
2016
Q4 | $815M | Sell |
16,922,423
-209,900
| -1% | -$10.4M | 0.11% | 196 |
|
|
2016
Q3 | $924M | Buy |
17,132,323
+571,221
| +3% | +$31.3M | 0.12% | 176 |
|
|
2016
Q2 | $897M | Buy |
16,561,102
+3,805,790
| +30% | +$200M | 0.12% | 173 |
|
|
2016
Q1 | $647M | Buy |
12,755,312
+1,791,918
| +16% | +$89.2M | 0.09% | 230 |
|
|
2015
Q4 | $553M | Buy |
10,963,394
+1,841,504
| +20% | +$93.9M | 0.07% | 277 |
|
|
2015
Q3 | $438M | Buy |
9,121,890
+341,275
| +4% | +$17.8M | 0.06% | 337 |
|
|
2015
Q2 | $457M | Sell |
8,780,615
-1,178,939
| -12% | -$66.4M | 0.06% | 359 |
|
|
2015
Q1 | $575M | Buy |
9,959,554
+900,764
| +10% | +$51.6M | 0.07% | 310 |
|
|
2014
Q4 | $484M | Buy |
9,058,790
+1,331,432
| +17% | +$74.5M | 0.06% | 349 |
|
|
2014
Q3 | $444M | Buy |
7,727,358
+2,536,644
| +49% | +$156M | 0.06% | 343 |
|
|
2014
Q2 | $347M | Sell |
5,190,714
-83,850
| -2% | -$5.68M | 0.05% | 442 |
|
|
2014
Q1 | $352M | Sell |
5,274,564
-124,697
| -2% | -$8.43M | 0.05% | 404 |
|
|
2013
Q4 | $360M | Sell |
5,399,261
-2,866,473
| -35% | -$186M | 0.05% | 399 |
|
|
2013
Q3 | $518M | Sell |
8,265,734
-1,001,998
| -11% | -$64.5M | 0.08% | 289 |
|
|
2013
Q2 | $579M | Buy |
+9,267,732
| New | +$588M | 0.09% | 244 |
|
Other funds holding GSK
JEST
Fidelity Investments's GSK Position: Q2 2026 in Review
Fidelity Investments reduced its GSK (GSK) stake by 4% in Q2 2026, selling an estimated $143M and leaving 64,961,641 shares worth $3.41B. The position accounts for 0.15% of the portfolio, ranked #111.
Fidelity Investments first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.73B in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Fidelity Investments held 64,961,641 shares of GSK worth $3.41B as of Q2 2026.
- Fidelity Investments sold 2,700,005 GSK shares in Q2 2026, an estimated $143M.
- GSK made up 0.15% of Fidelity Investments's portfolio in Q2 2026, its #111 holding.
- Fidelity Investments first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
- Fidelity Investments's GSK position peaked at $3.73B in Q1 2026.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.